An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-05-089458PMID 17971488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cdc42 GTPase-activating protein deficiency promotes genomic instability and premature aging-like phenotypes

  2007cited by this paper
• Targeting BCL‐2 family proteins to overcome drug resistance in non‐small cell lung cancer

  2007cited by this paper
• Improving T cell therapy for cancer.

  2007cited by this paper
• Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

  2007cited by this paper
• Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak

  2007cited by this paper
• Immunosuppressive strategies that are mediated by tumor cells.

  2007cited by this paper
• Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure

  2006cited by this paper
• Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling.

  2006cited by this paper
• Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

  2006cited by this paper
• Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts.

  2006cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking.

  2006cited by this paper
• The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

  2006cited by this paper
• Improving T cell therapy for cancer

  2006cited by this paper
• Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

  2006cited by this paper
• The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

  2006cited by this paper
• Tumor cells caught in the act of invading: their strategy for enhanced cell motility.

  2005cited by this paper
• Rho GTPases and the control of cell behaviour.

  2005cited by this paper
• Cdc42GAP regulates c-Jun N-terminal kinase (JNK)-mediated apoptosis and cell number during mammalian perinatal growth.

  2005cited by this paper
• SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity.

  2005cited by this paper
• Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

  2005cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo

  2005cited by this paper
• The Pathophysiology of Mitochondrial Cell Death

  2004cited by this paper
• Cancer Immunotherapy: A Treatment for the Masses

  2004cited by this paper
• Overexpression of RhoA, Rac1, and Cdc42 GTPases Is Associated with Progression in Testicular Cancer

  2004cited by this paper
• Cdc42: new roads to travel.

  2004cited by this paper
• Molecules and mechanisms of the graft-versus-leukaemia effect

  2004cited by this paper
• The Bcl2 family: regulators of the cellular life-or-death switch

  2002cited by this paper
• Antiapoptotic Cdc42 mutants are potent activators of cellular transformation.

  2002cited by this paper
• Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

  2001cited by this paper
• Haematopoietic cell transplantation as immunotherapy

  2001cited by this paper
• Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability.

  2000cited by this paper
• Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation

  2000cited by this paper
• Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases.

  2000cited by this paper
• MAPK/ERK signaling in activated T cells inhibits CD95/Fas‐mediated apoptosis downstream of DISC assembly

  2000cited by this paper
• Rho GTPases are over‐expressed in human tumors

  1999cited by this paper
• Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.

  1999cited by this paper
• Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes

  1997cited by this paper
• Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K

  1997cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper
• Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation

  1997cited by this paper
• Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome.

  1996cited by this paper
• Targeting p53 as a general tumor antigen.

  1995cited by this paper
• Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

  1991cited by this paper
• Database

  1985cited by this paper
• Specificity of short-loop feedback of luteinizing hormone in the rabbit.

  1979cited by this paper

• Serum CDC42 level change during abiraterone plus prednisone treatment and its association with prognosis in metastatic castration-resistant prostate cancer patients

  2025cites this paper
• UBE2T/CDC42/CD276 signaling axis mediates brain metastasis of triple-negative breast cancer via lysosomal autophagy

  2025cites this paper
• Serum cell division control 42 reflects treatment response and survival profiles in recurrent or metastatic oral squamous cell carcinoma patients who receive programmed death-1 inhibitors.

  2024cites this paper
• Vertical level of blood cell division cycle 42 predicts response and survival benefits to PD-1 inhibitor-based regimen in metastatic colorectal cancer patients

  2023cites this paper
• Serum Cell Division Cycle 42 before and after Programmed Death-1 Inhibitor Therapy in Advanced Melanoma Patients: Correlation with Tumor Features, Clinical Response, and Survival.

  2023influential citation
• Serum cell division cycle 42 reflects the treatment response and survival in patients with advanced cervical cancer who receive immune checkpoint inhibitor treatment

  2023cites this paper
• Serum cell division cycle 42 in advanced hepatocellular carcinoma patients: linkage with clinical characteristics and immune checkpoint inhibitor-related treatment outcomes.

  2023cites this paper
• The relation of blood cell division control protein 42 level with disease risk, comorbidity, tumor features/markers, and prognosis in colorectal cancer patients

  2022cites this paper
• Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer

  2022cites this paper
• Tumour cell CD99 regulates transendothelial migration via CDC42 and actin remodelling.

  2021cites this paper
• RhoGTPase Signalling in Cancer Progression and Dissemination.

  2021cites this paper
• Tumour cell CD99 regulates transendothelial migration via CDC42 and actin remodelling

  2021cites this paper
• Future Challenges in Cancer Resistance to Immunotherapy.

  2020cites this paper
• Cell-mediated immune resistance in cancer

  2020cites this paper
• Future Challenges in Cancer Resistance to Immunotherapy

  2020cites this paper
• Actin Cytoskeleton Straddling the Immunological Synapse between Cytotoxic Lymphocytes and Cancer Cells

  2019cites this paper
• CD99 regulates cancer cell transendothelial migration and endothelial cell function via CDC42 and actin remodelling

  2019cites this paper
• Rho GTPase effectors and NAD metabolism in cancer immune suppression

  2018cites this paper
• Protein Surface Recognition by Synthetic Molecules

  2017cites this paper
• Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy

  2017cites this paper
• Hypoxia: A Key Feature of the Tumor Microenvironment Triggers Several Mechanisms of Evasion from Natural Killer and Cytotoxic T Lymphocytes Surveillance

  2016cites this paper
• Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression.

  2015cites this paper
• Essential roles of Cdc42 and MAPK in cadmium-induced apoptosis in Litopenaeus vannamei.

  2015cites this paper
• miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells

  2014cites this paper
• Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity

  2014cites this paper
• lymphoma to Rituximab-induced apoptosis Targeting Bcl-2 family proteins modulates the sensitivity of B-cell

  2013cites this paper
• Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade

  2013cites this paper
• Identification of Relevant Cancer Related-Genes in the Flat Oyster Ostrea edulis Affected by Disseminated Neoplasia

  2012cites this paper
• miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.

  2011cites this paper
• Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.

  2010cites this paper
• Synthesis and biological evaluation of a 5-6-5 imidazole-phenyl-thiazole based alpha-helix mimetic.

  2009cites this paper
• SWAP‐70‐like adapter of T cells: a novel Lck‐regulated guanine nucleotide exchange factor coordinating actin cytoskeleton reorganization and Ca2+ signaling in T cells

  2009cites this paper
• Tyrosine-phosphorylation-dependent translocation of the SLAT protein to the immunological synapse is required for NFAT transcription factor activation.

  2008cites this paper
• Modulation of the Tumor Cell Phenotype by IFN-γ Results in Resistance of Uveal Melanoma Cells to Granule-Mediated Lysis by Cytotoxic Lymphocytes1

  2008cites this paper
• Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis.

  2008cites this paper
• CDC 42 ( cell division cycle 42 ( GTP binding protein , 25 kDa ) )

  year unknowncites this paper